Chemotherapy of Bladder Carcinoma with Cyclophosphamide and Adriamycin (Q41995507)

15 October 2017

Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

Chemotherapy of Bladder Carcinoma with Cyclophosphamide and Adriamycin (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

26 October 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

26 October 2023

author name string

C. Merrin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

R. Cartagena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

Z. Wajsman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

G. Baumgartner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

G. P. Murphy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1195468

31 August 2022

language of work or name

English

0 references

publication date

1 December 1975

1 reference

full work available at URL

15 October 2017

https://api.elsevier.com/content/article/PII:S0022534717671659?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

https://api.elsevier.com/content/article/PII:S0022534717671659?httpAccept=text/plain

26 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2967165-9

26 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

26 October 2023

1 reference

15 October 2017

114

1 reference

15 October 2017

6

1 reference

15 October 2017

884-887

1 reference

Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth

15 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Cancer of the urogenital tract: bladder cancer. The radiation attack.

26 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases

26 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms

26 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Meaningful clinical classification of therapeutic responses to anticancer drugs

26 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Chemotherapy of bladder carcinoma with 5-fluorouracil

26 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Chemotherapy of human solid tumors with 5-fluorouracil

26 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

Methotrexate treatment for advanced bladder cancer

26 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67165-9

26 October 2023

Identifiers

0 references

1 reference